- Home
- KZIA vs BUDA Comparison
KZIA vs BUDA Comparison
Compare KZIA & BUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KZIA | BUDA |
|---|---|---|
| Founded | 1994 | 2013 |
| Country | Australia | United States |
| Employees | N/A | 39 |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 110.1M |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | KZIA | BUDA |
|---|---|---|
| Price | $11.34 | $8.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $19.50 | $14.00 |
| AVG Volume (30 Days) | ★ 194.9K | 7.9K |
| Earning Date | 06-04-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.42 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.86 | $7.61 |
| 52 Week High | $17.40 | $10.70 |
Technical Indicators
Market Signals| Indicator | KZIA | BUDA |
|---|---|---|
| Relative Strength Index (RSI) | 44.20 | 35.92 |
| Support Level | $5.62 | N/A |
| Resistance Level | $14.57 | $10.42 |
| Average True Range (ATR) | 1.07 | 0.63 |
| MACD | -0.29 | -0.06 |
| Stochastic Oscillator | 21.55 | 25.66 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About BUDA Buda Juice Inc. Common Stock
Buda Juice Inc operates in a beverage industry, focused on fresh, cold-crafted juice production for business-to-business (B2B) distribution. The Company mostly utilizes third-party delivery systems and operates within the State of Texas serving large, national chain grocery stores. It is pioneering a new category in beverages-UltraFresh juice-offering cold-crafted citrus-based drinks that are never heat-treated, pasteurized, never HPP- processed, never UV- treated and always cold.